Company page

Gain Therapeutics, Inc.

Gain Therapeutics, Inc. (ticker: GANX) is a public company based in the United States, with a market capitalization of approximately $72.9 million. The company focuses on developing innovative therapies for various diseases. Gain Therapeutics is committed to advancing its research and development efforts to bring new treatment options to market.